The changes of serum adipocytokines levels in patients with OSAHS Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I Year: 2011
Determinants of serum leptin and adiponectin levels in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005
The relationship of plasma adropin levels in pediatric obese patients with OSA Source: International Congress 2019 – New developments in sleep-disordered breathing, gas exchange and lung function in children Year: 2019
Relation of serum ghrelin and leptin levels to blood gases disturbance in obesity hypoventilation syndrome patients Source: Annual Congress 2009 - Noninvasive ventilation: new and old aspects Year: 2009
Serum leptin levels in patients with chronic airway diseases Source: Eur Respir J 2005; 26: Suppl. 49, 306s Year: 2005
Assessment of serum leptin level in the Egyptian asthmatic patients Source: Annual Congress 2012 - Aspects of clinical asthma Year: 2012
Leptin, adiponectin and ghrelin levels in female patients with asthma during stable and exacerbation periods Source: Annual Congress 2012 - Cell biology and inflammatory gene expression in chronic lung disease Year: 2012
Leptin daytime urine secretion corresponds to OSA severity Source: Eur Respir J 2004; 24: Suppl. 48, 566s Year: 2004
Effects of different serum theophylline concentrations on erythropoietin and hematocrit levels in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 422s Year: 2003
Role of plasmatic leptin in response to hypercapnia in obese patients with or without OSAS Source: Annual Congress 2007 - Pathogenesis of obstructive sleep apnoea Year: 2007
Serum levels of circulating adipocytokines, leptin and adiponectin, in obstructive sleep apnea Source: Eur Respir J 2004; 24: Suppl. 48, 692s Year: 2004
Serum leptin levels in obstructive sleep apnoea patients Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Blood glucose levels assessed by serum fructosamine in children treated with inhaled salbutamol Source: Eur Respir J 2005; 26: Suppl. 49, 617s Year: 2005
Serum levels of TGFβ and VEGF in lung cancer patients and healthy subjects Source: Eur Respir J 2004; 24: Suppl. 48, 43s Year: 2004
3 month continuous positive airway pressure (CPAP) therapy decreases serum lipids, but not homocysteine and leptin concentration in patients with OSAS Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009
Plasma levels of NT-proBNP in OSAS patients before CPAP treatment. Relationship to ventricular dysfunction. Preliminary results Source: Eur Respir J 2006; 28: Suppl. 50, 415s Year: 2006
Serum lipid levels in patients with bronchiectasis Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008
Gender differences in plasma biomarkers levels in patients with COPD Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010
Plasma leptin in asthma patients with steroid induced diabetes compared with obesity patients Source: Eur Respir J 2007; 30: Suppl. 51, 555s Year: 2007
Serum neopterin and IL-6 as biomarkers in patients with COPD. Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017